For a localized hidradenocarcinoma of the extremity managed with resection, what adjuvant dose to the surgical bed would you recommend?
1 Answers
Mednet Member
Radiation Oncology · University of Oklahoma College of Medicine
Hidradenocarcinoma is an extremely rare pathologic condition. Over the past five years I have treated many patients with hidradenitis suppurativa with surprisingly good results, but I have yet to see a malignancy arising in any of these areas. My advice would be to treat these patients as you would ...